Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
A rare mitochondrial oxidative phosphorylation disorder characterized by myoclonic seizures, ataxia, generalized epilepsy, muscle weakness and ragged red fibers in the muscle biopsy. |
Is a |
False |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Kearns-Sayre syndrome |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Mitochondrial-lipid-glycogen storage myopathy |
Is a |
False |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Juvenile myopathy, encephalopathy, lactic acidosis, stroke (disorder) |
Is a |
False |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Leber's optic atrophy |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
[X]Mitochondrial myopathy, not elsewhere classified |
Is a |
False |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Congenital hyperammonemia, type I |
Is a |
False |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Cytochrome-c oxidase deficiency |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Mitochondrial myopathy |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Histiocytoid mitochondrial cardiomyopathy due to cytochrome aa3 deficiency (disorder) |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
2 |
Mitochondrial cardiomyopathy (disorder) |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
1 |
Hypertrophic mitochondrial cardiomyopathy (disorder) |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
1 |
Histiocytoid mitochondrial cardiomyopathy (disorder) |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
2 |
Hypertrophic mitochondrial cardiomyopathy associated with cataracts and lactic acidosis (disorder) |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
3 |
Fatal infantile mitochondrial cardiomyopathy (disorder) |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
2 |
Maternally inherited mitochondrial cardiomyopathy and myopathy |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
3 |
Family history of mitochondrial disease |
Associated finding |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
1 |
Childhood myocerebrohepatopathy spectrum (disorder) |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Mitochondrial metabolism defect |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Deficiency of mitochondrial complex III |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare neuro-ophthalmological disease associating the typical optic atrophy with other extra-ocular manifestations such as sensorineural deafness, myopathy, chronic progressive external ophthalmoplegia, ataxia and peripheral neuropathy. More rarely, other manifestations have been associated with this condition, such as spastic paraplegia or multiple-sclerosis like illness. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial disease characterized by adult onset of the triad of sensory ataxic neuropathy, dysarthria, and ophthalmoparesis. Additional signs and symptoms are highly variable and include myopathy, seizures, and hearing loss, among others. Brain imaging may show cerebellar white matter abnormalities and/or bilateral thalamic lesions. |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
3 |
Maternally-inherited mitochondrial dystonia is a rare neurological mitochondrial DNA-related disorder characterized clinically by progressive pediatric-onset dystonia with variable degrees of severity. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Cardiomyopathy-hypotonia-lactic acidosis syndrome is characterized by hypertrophic cardiomyopathy, muscular hypotonia and the presence of lactic acidosis at birth. It has been described in two sisters (both of whom died within the first year of life) from a nonconsanguineous Turkish family. The syndrome is caused by a homozygous point mutation in the exon 3A of the SLC25A3 gene encoding a mitochondrial membrane transporter. |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
3 |
A rare mitochondrial disorder characterized by facial dysmorphism similar to that seen in Zellweger syndrome, such as frontal bossing, high forehead, upslanting palpebral fissures, hypoplastic supraorbital ridges, and epicanthal folds, and in addition, pale skin, profound hypotonia, developmental delay, and minor metabolic anomalies. No peroxisomal defects, however, have been reported. Transmission is thought to be autosomal recessive. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation deficiency type 3 is an extremely rare clinically heterogeneous disorder described in about 5 patients to date. Clinical signs included hypotonia, lactic acidosis, and hepatic insufficiency, with progressive encephalomyopathy or hypertrophic cardiomyopathy. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Congenital cataract - hypertrophic cardiomyopathy - mitochondrial myopathy (CCM) is a mitochondrial disease characterized by cataracts, hypertrophic cardiomyopathy, muscle weakness and lactic acidosis after exercise. |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
3 |
A rare X-linked syndromic intellectual disability characterized by mild to profound intellectual disability, microcephaly, growth delay, and hypogenitalism. Obesity, early-onset diabetes and epilepsy are more variably present. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
syndrome de tubulopathie proximale-diabète sucré-ataxie cérébelleuse |
Is a |
False |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial disease that has a heterogeneous clinical presentation characterized by the association of progressive sensorineural hearing loss with hypertrophic cardiomyopathy and, in the majority of cases, encephalomyopathy symptoms such as ataxia, slurred speech, progressive external ophthalmoparesis (PEO), muscle weakness, myalgia, and exercise intolerance. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Infantile-onset spinocerebellar ataxia (IOSCA) is a hereditary neurological disorder with early and severe involvement of both the peripheral and central nervous systems. It has only been described in Finnish families. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
This syndrome is characterized by severe hypotonia, lactic acidemia and congenital hyperammonemia. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
This syndrome is characterized by childhood-onset progressive ataxia and cerebellar atrophy. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Demyelination of central nervous system co-occurrent and due to mitochondrial disease (disorder) |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
1 |
Demyelination of central nervous system co-occurrent and due to mitochondrial disease (disorder) |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Epileptic encephalopathy with global cerebral demyelination is a rare mitochondrial substrate carrier disorder characterized by severe muscular hypotonia, seizures (with or without episodic apnea) beginning in the first year of life, and arrested psychomotor development (affecting mainly motor skills). Severe spasticity with hyperreflexia has also been reported. Global cerebral hypomyelination is a characteristic imaging feature of this disease. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation defect type 8 is a mitochondrial disease due to a defect in mitochondrial protein synthesis resulting in deficiency of respiratory chain complexes I, III and IV in the cardiac and skeletal muscle and brain characterised by severe hypertrophic cardiomyopathy, pulmonary hypoplasia, generalised muscle weakness and neurological involvement. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
This disease is characterized by progressive cerebellar ataxia with pyramidal and spinal cord dysfunction, associated with distinctive MRI anomalies and increased lactate in the abnormal white matter. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Liver disease co-occurrent and due to mitochondrial disorder (disorder) |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
2 |
Liver disease co-occurrent and due to mitochondrial disorder (disorder) |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation defect type 13 is a rare mitochondrial disease due to a defect in mitochondrial protein synthesis characterized by normal early development followed by the sudden onset in infancy of poor feeding, dysphagia, truncal (followed by global) hypotonia, motor regression, abnormal movements (i.e. severe dystonia of limbs, choreoathetosis, facial dyskinesias) and reduced tendon reflexes. The disease course is severe but nonprogressive. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation defect type 15 is a rare mitochondrial disease due to a defect in mitochondrial protein synthesis characterized by onset in infancy or early childhood of muscular hypotonia, gait ataxia, mild bilateral pyramidal tract signs, developmental delay (affecting mostly speech and coordination) and subsequent intellectual disability. Short stature, obesity, microcephaly, strabismus, nystagmus, reduced visual acuity, lactic acidosis, and a brain neuropathology consistent with Leigh syndrome are also reported. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation defect type 7 is a rare mitochondrial disease due to a defect in mitochondrial protein synthesis characterized by a variable phenotype that includes onset in infancy or early childhood of failure to thrive and psychomotor regression (after initial normal development), as well as ocular manifestations (such as ptosis, nystagmus, optic atrophy, ophthalmoplegia and reduced vision). Additional manifestations include bulbar paresis with facial weakness, hypotonia, difficulty chewing, dysphagia, mild dysarthria, ataxia, global muscle atrophy, and areflexia. It has a relatively slow disease progression with patients often living into the third decade of life. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation defect type 9 is a rare mitochondrial disease due to a defect in mitochondrial protein synthesis characterized by initially normal growth and development followed by the infantile onset of failure to thrive, psychomotor delay, poor feeding, dyspnea, severe hypertrophic cardiomyopathy and hepatomegaly. Laboratory studies report increased plasma lactate and alanine, abnormal liver enzymes and decreased activity of mitochondrial respiratory chain complexes I, III, IV, and V. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation defect type 21 is a rare mitochondrial disease characterized by axial hypotonia with limb hypertonia, developmental delay, hyperlactatemia, central nervous system anomalies visible on magnetic resonance imaging (e.g. corpus callosum hypoplasia, lesions of the globus pallidus) and multiple deficiency of the mitochondrial respiratory chain complexes in muscle tissue, but not in fibroblasts or liver. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome is a rare mitochondrial disease due to a defect in coenzyme Q10 biosynthesis that manifests with a broad spectrum of signs and symptoms which may include: neonatal lactic acidosis, global developmental delay, tonus disorder, seizures, reduced spontaneous movements, ventricular hypertrophy, bradycardia, renal tubular dysfunction with massive lactic acid excretion in urine, severe biochemical defect of respiratory chain complexes II/III when assayed together and deficiency of coenzyme Q10 in skeletal muscle. Cerebral and cerebellar atrophy can be seen on magnetic resonance imaging and multiple choroid plexus cysts and symmetrical hyperechoic signal alterations in basal ganglia have been observed on ultrasound. |
Is a |
False |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare, genetic neurological disorder defined by early-onset of neurologic symptoms, biphasic clinical course, unique MRI features (including extensive, symmetrical, deep white matter abnormalities), and increased lactate in body fluids. The severe form is characterized by delayed psychomotor development, seizures, early-onset hypotonia, and persistently increased lactate levels. The mild form usually presents with irritability, psychomotor regression after six months of age, and temporary high lactate levels, with overall clinical improvement from the second year onward. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation defect type 2 is a rare mitochondrial disorder due to a defect in mitochondrial protein synthesis characterized by severe intrauterine growth retardation, neonatal limb edema and redundant skin on the neck (hydrops), developmental brain defects (corpus callosum agenesis, ventriculomegaly), brachydactyly, dysmorphic facial features with low set ears, severe intractable neonatal lactic acidosis with lethargy, hypotonia, absent spontaneous movements and fatal outcome. Markedly decreased activity of complex I, II + III and IV in muscle and liver have been determined. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation defect type 4 is a rare mitochondrial disorder due to a defect in mitochondrial protein synthesis characterized by a neonatal onset of severe metabolic acidosis and respiratory distress, persistent lactic acidosis with episodes of metabolic crises, developmental regression, microcephaly, abnormal gaze fixation and pursuit, axial hypotonia with limb spasticity and reduced spontaneous movements. Neuroimaging studies reveal polymicrogyria, white matter abnormalities and multiple cystic brain lesions, including basal ganglia, and cerebral atrophy. Decreased activity of complex I and IV have been determined in muscle biopsy. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome is a rare hereditary spastic ataxia disorder characterized by childhood onset of slowly progressive lower limb spastic paraparesis and cerebellar ataxia (with dysarthria, swallowing difficulties, motor degeneration), associated with sensorimotor neuropathy (including muscle weakness and distal amyotrophy in lower extremities) and progressive myoclonic epilepsy. Ocular signs (ptosis, oculomotor apraxia), dysmetria, dysdiadochokinesia, dystonic movements and myoclonus may also be associated. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial oxidative phosphorylation disorder with complex I and IV deficiency characterized by hypertrophic cardiomyopathy, hepatic steatosis with elevated liver transaminases, exercise intolerance and muscle weakness. Neuro-ophthalmological features (hemiplegic migraine, Leigh-like lesions on brain MRI, pigmentary retinopathy) have been reported later in life. |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
2 |
A rare mitochondrial oxidative phosphorylation disorder with complex I and IV deficiency characterized by hypertrophic cardiomyopathy, hepatic steatosis with elevated liver transaminases, exercise intolerance and muscle weakness. Neuro-ophthalmological features (hemiplegic migraine, Leigh-like lesions on brain MRI, pigmentary retinopathy) have been reported later in life. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A mitochondrial oxidative phosphorylation disorder characterized by hypertrophic and dilated cardiomyopathy, failure to thrive, myopathy with generalized hypotonia and increased creatine kinase, developmental delay and/or regression with cerebral atrophy on brain MRI, renal manifestations including chronic renal failure, renal tubular acidosis and lactic acidosis. Additional clinical features include seizures and respiratory failure. |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
4 |
A rare mitochondrial oxidative phosphorylation disorder with complex I and IV deficiency characterized by lactic acidosis, hypotonia, hypertrophic cardiomyopathy and global developmental delay. Other clinical features include feeding difficulties, failure to thrive, seizures, optic atrophy and ataxia. |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
2 |
A rare mitochondrial oxidative phosphorylation disorder with complex I and IV deficiency characterized by lactic acidosis, hypotonia, hypertrophic cardiomyopathy and global developmental delay. Other clinical features include feeding difficulties, failure to thrive, seizures, optic atrophy and ataxia. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency is a rare, hereditary, mitochondrial oxidative phosphorylation disorder characterized by severe neonatal lactic acidosis and deficiency of mitochondrial complexes I, II and III. Clinical features are variable and may include hypotonia, respiratory distress with cyanosis, failure to thrive, feeding difficulties, hypoglycemia, dehydration, vomiting, seizures, and a risk of multiple organ failure. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation defect type 14 is a rare mitochondrial disease due to a defect in mitochondrial protein synthesis characterized by neonatal or infancy-onset of seizures that are refractory to treatment, delayed or absent psychomotor development and lactic acidosis. Additional manifestations reported include poor feeding, failure to thrive, microcephaly, hypotonia, anemia and thrombocytopenia. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation defect type 17 is a rare, genetic, mitochondrial disorder due to a defect in mitochondrial protein synthesis characterized by infantile onset of severe hypertrophic cardiomyopathy (that occasionally progresses to dilated cardiomyopathy) associated with failure to thrive, global development delay, muscular hypotonia, elevated serum lactate and complex I deficiency in skeletal muscle biopsy. Intellectual disability, pericardial effusion and a mild cardiac phenotype have been also reported. |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
2 |
Combined oxidative phosphorylation defect type 17 is a rare, genetic, mitochondrial disorder due to a defect in mitochondrial protein synthesis characterized by infantile onset of severe hypertrophic cardiomyopathy (that occasionally progresses to dilated cardiomyopathy) associated with failure to thrive, global development delay, muscular hypotonia, elevated serum lactate and complex I deficiency in skeletal muscle biopsy. Intellectual disability, pericardial effusion and a mild cardiac phenotype have been also reported. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare complex hereditary spastic paraplegia characterized by adulthood-onset of slowly progressive, bilateral, mainly lower limb spasticity and distal weakness associated with lower limb pain, hyperreflexia, and reduced vibration sense. Axonal neuropathy is frequently observed on electromyography and nerve conduction examination. |
Is a |
False |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare, genetic, mitochondrial disease characterized by early-onset progressive renal failure, manifesting with hyperuricemia, hyponatremia, hypomagnesemia, hypochloremic metabolic alkalosis, elevated BUN and polyuria, associated with systemic manifestations which include pulmonary hypertension, failure to thrive, global developmental delay, hypotonia and ventricular hypertrophy. Additional features include prematurity, elevated serum lactate, diabetes mellitus and, in some, pancytopenia. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare neurometabolic disease characterized by a neonatal onset of seizures (often intractable), muscular hypotonia, feeding difficulties (poor sucking and/or swallowing) and mild to severe psychomotor delay, associated with nonketotic hyperglycinemia typically revealed by biochemical analysis. Respiratory problems (apnea, acute respiratory acidosis), lethargy, hearing loss, microcephaly and spasticity with pyramidal signs may also be associated. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare inborn error of metabolism disorder, with a highly variable phenotype, typically characterized by neonatal to infancy-onset of seizures, psychomotor delay, and abnormal muscle tone that may include hypo- and/or hypertonia, resulting in generalized weakness, dystonic movements, and/or progressive respiratory distress, associated with severe lactic acidosis and elevated lactate, ketoglutarate and 2-oxoacids in urine. Additional manifestations may include dehydration, vomiting, signs of liver dysfunction, extrapyramidal signs, spastic tetraparesis, brisk deep tendon reflexes, speech impairment, swallowing difficulties, and pulmonary hypertension. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare, syndromic, hereditary optic neuropathy disorder characterized by early-onset, severe, progressive visual impairment, optic disc pallor and central scotoma, variably associated with dyschromatopsia, auditory neuropathy (e.g. mild progressive sensorineural hearing loss), sensorimotor axonal neuropathy and, occasionally, moderate hypertrophic cardiomyopathy. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial oxidative phosphorylation disorder characterized by variable combination of psychomotor delay, hypotonia, muscle weakness, seizures, microcephaly, cardiomyopathy and mild dysmorphic facial features. Variable types of structural brain anomalies have also been reported. Biochemical studies typically show decreased activity of mitochondrial complexes (mainly complex I). |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare, genetic, mitochondrial oxidative phosphorylation disorder characterized by a highly variable phenotype which ranges from a fatal neonatal/infantile encephalomyopathy with lactic acidosis, hyporeflexia/areflexia, severe hypotonia and respiratory failure to less severe cases presenting with central hypotonia, global developmental delay, congenital sensorineural hearing loss, and renal disease. Additional, variably observed, clinical features include intellectual disability, seizures, and cardiomyopathy. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare, genetic, autosomal recessive spastic ataxia disease characterized by onset in early childhood of spastic paraparesis, cerebellar ataxia, dysarthria and optic atrophy. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Gonadal dysgenesis with auditory dysfunction, autosomal recessive inheritance |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare genetic, neuro-ophthalmological disease characterized by progressive weakness of the external eye muscles, resulting in bilateral ptosis and diffuse symmetric ophthalmoparesis. Additional signs may include skeletal muscle weakness, cataracts, hearing loss, sensory axonal neuropathy, ataxia, parkinsonism, cardiomyopathy, hypogonadism and depression. It is usually less severe than autosomal recessive form. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare genetic, neuro-ophthalmological disease characterized by progressive weakness of the external eye muscles, resulting in bilateral ptosis and diffuse, symmetric ophthalmoparesis. Additional signs may include generalized skeletal muscle weakness, muscle atrophy, sensory axonal neuropathy, ataxia, cardiomyopathy, and psychiatric symptoms. It is usually more severe than autosomal dominant form. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Maternally inherited diabetes and deafness (disorder) |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Dilated cardiomyopathy due to mitochondrial disease |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
2 |
Glomerular disease due to mitochondrial cytopathy |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
2 |
Chronic diarrhea with villous atrophy is a rare, genetic gastroenterological disease characterized by the early onset of chronic diarrhea, vomiting, anorexia, lactic acidosis, renal insufficiency and hepatic involvement (mild elevation of liver enzymes, steatosis, hepatomegaly). Partial villous atrophy (with eosinophilic infiltration) is observed on intestinal biopsy. Although diarrhea may resolve, the development of neurologic symptoms (cerebellar ataxia, sensorineural deafness, seizures), retinitis pigmentosa and muscle weakness may complicate disease course and lead to death. There have been no further descriptions in the literature since 1994. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome is a rare mitochondrial disease due to a defect in coenzyme Q10 biosynthesis that manifests with a broad spectrum of signs and symptoms which may include: neonatal lactic acidosis, global developmental delay, tonus disorder, seizures, reduced spontaneous movements, ventricular hypertrophy, bradycardia, renal tubular dysfunction with massive lactic acid excretion in urine, severe biochemical defect of respiratory chain complexes II/III when assayed together and deficiency of coenzyme Q10 in skeletal muscle. Cerebral and cerebellar atrophy can be seen on magnetic resonance imaging and multiple choroid plexus cysts and symmetrical hyperechoic signal alterations in basal ganglia have been observed on ultrasound. |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
4 |
A rare mitochondrial disease characterized by signs and symptoms within a phenotypic and metabolic spectrum that includes global developmental delay, hypotonia, intellectual disability, optic atrophy, axonal neuropathy, hypertrophic cardiomyopathy, lactic acidosis, and increased excretion of Krebs cycle intermediates. Other variable features are spasticity, seizures, ataxia, congenital cataract, and dysmorphic facial features. Age of onset is in the neonatal period or infancy. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome is rare, genetic, neurometabolic disease characterized by global developmental delay, severe hypotonia, seizures, cataracts, cardiomyopathy (including left or bi-ventricular hypertrophy, dilated cardiomyopathy) and left ventricular non-compaction, typically resulting in infantile or early-childhood death. Patients usually present metabolic lactic acidosis, failure to thrive, head lag, respiratory problems and decrease in respiratory chain complex activity. Highly variable cerebral abnormalities have been reported and include microcephaly, prominent extra-axial cerebrospinal fluid spaces, diffuse neuronal loss and cortical/white matter gliosis. |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
4 |
A rare mitochondrial oxidative phosphorylation disorder characterized by neonatal onset of hypotonia, feeding difficulties, deafness, and early fatal respiratory failure. Cardiac and liver involvement has been reported. Serum lactate is increased, and metabolic studies show decreased activity of mitochondrial respiratory complexes I and IV in skeletal muscle. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial oxidative phosphorylation disorder characterized by microcephaly, global developmental delay, spastic-dystonic movement disorder, intractable seizures, optic atrophy, autonomic dysfunction, and peripheral neuropathy. Serum lactate is increased, and muscle biopsy shows decreased activity of mitochondrial respiratory complexes I and III. Brain imaging reveals progressive cerebellar atrophy and delayed myelination. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial oxidative phosphorylation disorder characterized by a variable clinical phenotype including infantile onset of epileptic encephalopathy, hypotonia, global developmental delay, failure to thrive, complex movement disorder, and liver involvement, as well as childhood onset of severe myoclonus epilepsy, cognitive decline, progressive hearing and visual impairment, and progressive tetraparesis. Serum lactate may be increased, and brain imaging shows variable atrophy and white matter abnormalities. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial oxidative phosphorylation disorder characterized by a highly variable phenotype which may present as exercise intolerance with prominent exertional dyspnea, progressive muscle weakness, spasticity, and neuropathy, but without cognitive impairment or cardiac involvement, or as global developmental delay, growth retardation, hypotonia, and spasticity. Hypertrophic cardiomyopathy, optic atrophy, seizures, and dysmorphic facial features have also been reported in the more severe phenotype. Serum lactate may be elevated, and muscle biopsy shows myopathic features and variably decreased activity of mitochondrial respiratory chain complexes. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation defect type 25 is a rare mitochondrial oxidative phosphorylation disorder with decreased respiratory complex I and IV enzyme activities, characterized by hypotonia, global developmental delay, neonatal onset of progressive pectus carinatum without other skeletal abnormalities, poor growth, sensorineural hearing loss, dysmorphic features and brain abnormalities such as cerebral atrophy, quadriventricular dilatation and thin corpus callosum posteriorly. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial disease characterized by early onset of hypertrophic cardiomyopathy and variable neurologic symptoms including global developmental delay, hypotonia, intellectual disability, visual impairment, and seizures. Lactic acidosis is present in all patients. Muscle biopsy usually shows decreased activity of mitochondrial complexes I and IV. Brain imaging may reveal variable abnormal signal intensities in the thalamus, basal ganglia, and/or brain stem. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial disease characterized by early onset of hypertrophic cardiomyopathy and variable neurologic symptoms including global developmental delay, hypotonia, intellectual disability, visual impairment, and seizures. Lactic acidosis is present in all patients. Muscle biopsy usually shows decreased activity of mitochondrial complexes I and IV. Brain imaging may reveal variable abnormal signal intensities in the thalamus, basal ganglia, and/or brain stem. |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
4 |
A rare mitochondrial disease characterized by neonatal onset of severe cardiac and/or neurologic signs and symptoms mostly associated with a fatal outcome in the neonatal period or in infancy, although a milder phenotype with later onset and slowly progressive neurologic deterioration has also been reported. Clinical manifestations are variable and include respiratory insufficiency, hypotonia, cardiomyopathy, and seizures. Serum lactate is elevated in most cases. Brain imaging may show cerebellar atrophy or hypoplasia. |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
5 |
Maternally inherited mitochondrial myopathy (disorder) |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
2 |
Maternally inherited mitochondrial cardiomyopathy (disorder) |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
2 |
Non-syndromic mitochondrial sensorineural deafness (disorder) |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial disease characterized by a variable clinical phenotype ranging from fetal hydrops and postnatal hypotonia, bradycardia, and respiratory failure, resulting in death in the neonatal period, to infantile onset of episodes of acute cardiopulmonary failure associated with severe lactic acidosis, and slowly progressive muscle weakness. Muscle biopsy shows reduced activity of mitochondrial complexes I, III, and IV. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial disease characterized by prenatal or early infantile onset of severe cardiomyopathy, failure to thrive and global developmental delay, sensorineural hearing loss, and severe lactic acidosis. Hepatic involvement and adrenal insufficiency, as well as encephalopathy and anomalies of deep gray matter structures on brain MRI have also been reported. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial disease characterized by prenatal or early infantile onset of severe cardiomyopathy, failure to thrive and global developmental delay, sensorineural hearing loss, and severe lactic acidosis. Hepatic involvement and adrenal insufficiency, as well as encephalopathy and anomalies of deep gray matter structures on brain MRI have also been reported. |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
3 |
A rare mitochondrial disease characterized by a highly variable phenotypic spectrum comprising delayed motor development, peripheral neuropathy, cataract, short stature due to growth hormone deficiency, nystagmus, sensorineural hearing loss, dysmorphic facial features, and skeletal abnormalities consistent with spondyloepimetaphyseal dysplasia. Hyperextensible joints, achalasia, and telangiectasia have also been described. Cognition is normal. Atrophy of the pituitary gland has been observed in brain imaging. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial disease characterized by a distinctive MRI pattern of cavitating leukodystrophy, predominantly in the posterior region of the cerebral hemispheres. The clinical picture varies widely between acute neurometabolic decompensation in infancy with loss of developmental milestones, seizures, and pyramidal signs rapidly evolving into spastic tetraparesis, to subtle neurological symptoms presenting in adolescence. The disease course tends to stabilize over time in most patients, and marked recovery of milestones may be observed. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial disease characterized by bilateral auditory neuropathy and optic atrophy. Patients present hearing and visual impairment in the first or second decade of life, while psychomotor development is normal. Bilateral retinitis pigmentosa has been reported in association. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial disease characterized by a variable clinical phenotype with the core features of optic atrophy, ataxia, and hypotonia. Additional common manifestations include global developmental delay with or without regression, neuropathy, spasticity, and microcephaly, less frequently seizures, movement disorder, hearing loss, and respiratory failure. Brain imaging may show abnormalities of the corpus callosum, basal ganglia, and midbrain, cerebral or cerebellar atrophy, or white matter abnormalities. The condition is frequently fatal at an early age. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Combined oxidative phosphorylation defect type 24 is a rare mitochondrial oxidative phosphorylation disorder characterized by variable phenotype, including developmental delay with psychomotor regression, intellectual disability, epilepsy, Leigh syndrome, non-syndromic hearing loss, visual impairment and severe myopathy. Decreased activity of mitochondrial respiratory complexes and lactic acidosis are common findings, and diffuse cerebral atrophy may be associated. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare genetic neurological disorder characterized by childhood-onset dystonia with distinctive MRI changes in the basal ganglia, and optic atrophy developing either immediately or within a few years after the appearance of dystonia. Additional symptoms include chorea and other movement disorders, dysarthria, or nystagmus, among others. Motor disability progresses gradually, while cognitive function is relatively spared. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial disease characterised by a variable phenotype comprising delayed psychomotor development or neurodevelopmental regression, hypotonia, seizures, microcephaly, optic atrophy, pyramidal signs, and peripheral neuropathy, among others. Age of onset and disease severity are also variable with some cases taking a fatal course in early infancy. Serum lactate levels may be elevated. Reported brain imaging findings include abnormal signals in the basal ganglia, cerebral and/or cerebellar atrophy, and white matter abnormalities. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
A rare mitochondrial disease characterized by prenatal complications including oligohydramnios, fetal growth restriction, hydrops, and anemia, followed by severe lactic acidosis, hyaline membrane disease, pulmonary hypertension, cardiac anomalies, liver dysfunction, urogenital abnormalities and progressive renal disease, seizures, thrombocytopenia, and sideroblastic anemia resulting in multisystem organ failure and death shortly after birth. Less severely affected patients surviving the neonatal period and showing sensorineural hearing loss and developmental delay have been reported. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|
Chorea due to mitochondrial cytopathy |
Due to |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
2 |
A rare mitochondrial oxidative phosphorylation disorder characterized by a spectrum of three main clinical phenotypes comprising a severe neonatal phenotype with early fatal lactic acidosis, a more protracted course with early-onset developmental delay, motor weakness, extrapyramidal signs, with or without epilepsy, and a phenotype with normal early development and Parkinson-like symptoms starting around the age of one year. Additional, variably reported, signs and symptoms include cardiomyopathy, optic anomalies, hepatosplenomegaly, and abnormal brain MRI findings, among others. Deficiencies in mitochondrial oxidative phosphorylation enzymes are inconsistent. |
Is a |
True |
Mitochondrial cytopathy |
Inferred relationship |
Some |
|